Advertisement

PharmacoEconomics

, Volume 13, Issue 1, pp 51–59 | Cite as

Peripheral Arterial Obliterative Disease

Cost of Illness in France
  • Armelle Montron
  • Eric Guignard
  • Alain Pelc
  • Sylvie Comte
Original Research Article

Summary

The main purpose of this study, carried out in 1995, was to determine, using available sources, the cost of peripheral arterial obliterative disease (PAOD) in France over a 1-year period. This cost-of-illness study was based on a retrospective analysis of the available literature and databases. It involved a description of epidemiological data and a cost estimate of the different medical resources consumed over 1 year. For this latter purpose, a payer perspective was chosen.

Data were extracted from national representative surveys and databases with respect to morbidity and mortality [from the National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale; INSERM) and the National Sickness Insurance Fund for Salaried People (Caisse Nationale d’Assurance Maladie des Travailleurs Salariés; CNAMTS)], consultations, examination tests and drug prescriptions [from the French Medical Audit conducted by Intercontinental Medical Statistics (IMS)], hospitalisations [from the Statistical Unit of the Department of Health — Service des Statistiques, des Etudes et des Systemes d’Information (SESI) and the National Public Research Centre in Health Economics (Centre de Recherche d’Etude et de Documentation en Economie de la Santé; CREDES)] and related health expenditure from CNAMTS.

In France, the prevalence of stage II PAOD (Leriche and Fontaine classification) in 1992 was estimated to be 675 000; 53% of these patients had undergone vascular or bypass surgery. The total annual cost of healthcare (including consultations, drugs, laboratory tests, hospitalisation and hydrotherapy) for the management of patients with PAOD ranged from 3.9 billion French francs (F) to F4.6 billion (1995 values), depending on the type of hospital considered. 50% of this cost was related to hospitalisations and 75% was covered by the CNAMTS.

Although this study was only a partial evaluation and did not take into account indirect costs or nonmedical direct costs, such as transport and care by healthcare assistants and paramedics, these results may help to establish public health priorities and modify clinical practice to favour an earlier diagnosis of PAOD.

Keywords

Adis International Limited Peripheral Artery Disease Medical Resource Full Coverage French Franc 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Adis International Limited 1998

Authors and Affiliations

  • Armelle Montron
    • 1
  • Eric Guignard
    • 1
  • Alain Pelc
    • 1
  • Sylvie Comte
    • 2
  1. 1.Health Economics DepartmentIntercontinental Medical Statistics (IMS)NanterreFrance
  2. 2.Department of PharmacoeconomicsLIPHA LaboratoriesLyonFrance

Personalised recommendations